Please try another search
BAGSVÆRD, Denmark - Novo Nordisk (NYSE:NVO), a global healthcare company, has announced its agreement to purchase Cardior Pharmaceuticals for up to €1.025 billion, which includes both an...
Danish biotechnology research company Zealand Pharma (ZLDPF) saw its shares soar more than 35% in Copenhagen on Monday after following positive results from a trial of its liver disease treatment,...
Pharmaceutical companies Novo Nordisk (NYSE:NVO) A/S, GSK Plc, Haleon Plc, and BASF SE (OTC:BASFY) are scheduled to announce their financial results next week amidst a range of market conditions. Novo...
Novo Nordisk (NYSE:NVO), currently the most valuable European company, has revised its full-year guidance upwards, primarily due to a surge in U.S. sales of its semaglutide-based drugs, Wegovy and...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review